Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 60 Records) |
Query Trace: Carcinoma and PBRM1[original query] |
---|
Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population. Cancer cell international 2020 9 20 461. Zhao Qiang, Xue Jia, Hong Baoan, Qian Wubin, Liu Tiezhu, Fan Bin, Cai Jie, Ji Yongpeng, Liu Jia, Yang Yong, Li Qixiang, Guo Sheng, Zhang Ni |
A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response. Nature communications 2020 8 11 (1): 4168. Hakimi A Ari, Attalla Kyrollis, DiNatale Renzo G, Ostrovnaya Irina, Flynn Jessica, Blum Kyle A, Ged Yasser, Hoen Douglas, Kendall Sviatoslav M, Reznik Ed, Bowman Anita, Hwee Jason, Fong Christopher J, Kuo Fengshen, Voss Martin H, Chan Timothy A, Motzer Robert |
Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population. BMC urology 2020 Aug 20 (1): 125. Suh Jungyo, Jeong Chang Wook, Choi Seongmin, Ku Ja Hyeon, Kim Hyeon Hoe, Kim Kwangsoo, Kwak Che |
Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis. International journal of urology : official journal of the Japanese Urological Association 2020 7 27 (9): 790-797. Obeng Rebecca C, Arnold Rebecca S, Ogan Kenneth, Master Viraj A, Pattaras John G, Petros John A, Osunkoya Adeboye |
Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis. Journal for immunotherapy of cancer 2020 7 8 (2): . Dizman Nazli, Lyou Yung, Salgia Nicholas, Bergerot Paulo Gustavo, Hsu JoAnn, Enriquez Daniel, Izatt Tyler, Trent Jeffrey M, Byron Sara, Pal Suman |
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nature communications 2020 5 11 (1): 2135. Liu Xian-De, Kong Wen, Peterson Christine B, McGrail Daniel J, Hoang Anh, Zhang Xuesong, Lam Truong, Pilie Patrick G, Zhu Haifeng, Beckermann Kathryn E, Haake Scott M, Isgandrova Sevinj, Martinez-Moczygemba Margarita, Sahni Nidhi, Tannir Nizar M, Lin Shiaw-Yih, Rathmell W Kimryn, Jonasch Er |
Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data. Annals of translational medicine 2020 12 8 (21): 1389. Kim Ji-Yeon, Jeong Hyoung-Oh, Heo Dae Seog, Keam Bhumsuk, Moon Kyung Chul, Kwak Cheol, Jang Jinho, Kim Seunghoon, Kim Jong-Il, Lee Semin, Lee Se-Ho |
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade. Cancer cell 2020 11 38 (6): 803-817.e4. Motzer Robert J, Banchereau Romain, Hamidi Habib, Powles Thomas, McDermott David, Atkins Michael B, Escudier Bernard, Liu Li-Fen, Leng Ning, Abbas Alexander R, Fan Jinzhen, Koeppen Hartmut, Lin Jennifer, Carroll Susheela, Hashimoto Kenji, Mariathasan Sanjeev, Green Marjorie, Tayama Darren, Hegde Priti S, Schiff Christina, Huseni Mahrukh A, Rini Bri |
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness. BMC urology 2020 10 20 (1): 173. Eckel-Passow Jeanette E, Yan Huihuang, Kosel Matthew L, Serie Daniel, Decker Paul A, Jenkins Robert B, Costello Brian, Leibovich Bradley, Ho Thai H, Parker Alexand |
Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma. BioMed research international 2020 2020 2495157. Meng Hui, Jiang Xuewen, Cui Jianfeng, Yin Gang, Shi Benkang, Liu Qi, Xuan He, Wang |
Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. Urologic oncology 2021 9 39 (11): 791.e17-791.e24. Mano Roy, Duzgol Cihan, Ganat Maz, Goldman Debra A, Blum Kyle A, Silagy Andrew W, Walasek Aleksandra, Sanchez Alejandro, DiNatale Renzo G, Marcon Julian, Kashan Mahyar, Becerra Maria F, Benfante Nicole E, Coleman Jonathan A, Kattan Michael W, Russo Paul, Akin Oguz, Ostrovnaya Irina, Hakimi A A |
Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma. Cancers 2021 5 13 (9): . Moore Ariane L, Batavia Aashil A, Kuipers Jack, Singer Jochen, Burcklen Elodie, Schraml Peter, Beisel Christian, Moch Holger, Beerenwinkel Ni |
Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma. Aging 2021 4 13 (7): 9960-9975. Zeng Hao, Chen Linyan, Wang Manni, Luo Yuling, Huang Yeqian, Ma Xuel |
A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis. iScience 2021 3 24 (3): 102173. Niersch Jennifer, Vega-Rubín-de-Celis Silvia, Bazarna Anna, Mergener Svenja, Jendrossek Verena, Siveke Jens T, Peña-Llopis Samu |
Re: Masayuki Hagiwara, Atsushi Fushimi, Kazuhiro Matsumoto, Mototsugu Oya. The Significance of PARP1 as a Biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell Carcinoma. Eur Urol. 2022;81:145-8. European urology 2021 12 81 (3): e65. Wang Zhan, Zhao Yang, Zhang Yus |
Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma. Cancers 2021 12 13 (24): . Sauter-Meyerhoff Carolin, Bohnert Regina, Mazzola Pascale, Stühler Viktoria, Kandabarau Siarhei, Büttner Florian A, Winter Stefan, Herrmann Lisa, Rausch Steffen, Hennenlotter Jörg, Fend Falko, Scharpf Marcus, Stenzl Arnulf, Ossowski Stephan, Bedke Jens, Schwab Matthias, Schaeffeler El |
Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway. Oncology letters 2021 10 22 (6): 835. Gad Sophie, Le Teuff Gwenaël, Nguyen Baptiste, Verkarre Virginie, Duchatelle Veronique, Molinie Vincent, Posseme Katia, Grandon Benjamin, Da Costa Melanie, Job Bastien, Meurice Guillaume, Droin Nathalie, Mejean Arnaud, Couve Sophie, Renaud Flore, Gardie Betty, Teh Bin Tean, Richard Stephane, Ferlicot Soph |
Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification. Cancer science 2021 10 113 (1): 297-307. Yoshikawa Yoshie, Yamada Yusuke, Emi Mitsuru, Atanesyan Lilit, Smout Jan, de Groot Karel, Savola Suvi, Nakanishi-Shinkai Yukako, Kanematsu Akihiro, Nojima Michio, Ohmuraya Masaki, Hashimoto-Tamaoki Tomoko, Yamamoto Shin |
The Significance of PARP1 as a biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell Carcinoma. European urology 2021 10 81 (2): 145-148. Hagiwara Masayuki, Fushimi Atsushi, Matsumoto Kazuhiro, Oya Mototsu |
The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes. PloS one 2021 16 (1): e0245356. Huang Shih-Chiang, Ng Kwai-Fong, Chang Ian Yi-Feng, Chang Chee-Jen, Chao Yi-Chun, Chang Shu-Chen, Chen Min-Chi, Yeh Ta-Sen, Chen Tse-Chi |
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma. JCO precision oncology 2022 07 6 e2200012. Kotecha Ritesh R, Gedvilaite Erika, Ptashkin Ryan, Knezevic Andrea, Murray Samuel, Johnson Ian, Shapnik Natalie, Feldman Darren R, Carlo Maria I, Shah Neil J, Dunigan Marisa, Huberman Kety, Benayed Ryma, Zehir Ahmet, Berger Michael F, Ladanyi Marc, Tsui Dana W Y, Motzer Robert J, Lee Chung-Han, Voss Martin |
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. Molecular oncology 2022 3 16 (12): 2384-2395. van der Mijn Johannes C, Eng Kenneth W, Chandra Pooja, Fernandez Evan, Ramazanoglu Sinan, Sigaras Alexandros, Oromendia Clara, Gudas Lorraine J, Tagawa Scott T, Nanus David M, Faltas Bishoy F, Beltran Himisha, Sternberg Cora N, Elemento Olivier, Sboner Andrea, Mosquera Juan Miguel, Molina Ana |
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 2022 1 11 (1): 1993042. Lee Moon Hee, Järvinen Petrus, Nísen Harry, Brück Oscar, Ilander Mette, Uski Ilona, Theodoropoulos Jason, Kankainen Matti, Mirtti Tuomas, Mustjoki Satu, Kreutzman An |
Gene mutation profiling and clinical significances in patients with renal cell carcinoma. Clinics (Sao Paulo, Brazil) 2023 7 78 100259. Yongquan Wang, Peng He, Xiaozhou Zhou, Cong Wang, Jian Fu, Dawei Zhang, Deyang Liao, Zhansong Zhou, Chunman Wu, Wei Go |
Genomic profiles of renal cell carcinoma in a small Chinese cohort. Frontiers in oncology 2023 7 13 1095775. Sheng Tai, Dan-Dan Xu, Zhixian Yu, Yu Guan, Shuiping Yin, Jun Xiao, Song Xue, Chaozhao Lia |
Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis. Revista da Associacao Medica Brasileira (1992) 2023 5 69 (5): e20220415. Emin Demirel, Okan Dil |
Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (1): 100042. Yoshuantari Naomi, Jeng Yung-Ming, Liau Jau-Yu, Lee Chia-Hsiang, Tsai Jia-Hu |
PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers. Frontiers in genetics 2023 1 13 1066347. Dai Jiali, Cui Yanan, Liang Xiao, Xu Jiali, Li Jun, Chen Yu, Zhang Erbao, Guo Renh |
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis. Pathology, research and practice 2024 1 254 155142. Matteo Rosellini, Veronica Mollica, Andrea Marchetti, Sara Coluccelli, Francesca Giunchi, Elisa Tassinari, Costantino Ricci, Michelangelo Fiorentino, Giovanni Tallini, Dario De Biase, Francesco Massa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: